Rhythm Pharmaceuticals, Inc. (RYTM) financial statements (2021 and earlier)

Company profile

Business Address 222 BERKELEY STREET
BOSTON, MA 02116
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:292252148
Cash and cash equivalents625034
Short-term investments  114
Other undisclosed cash, cash equivalents, and short-term investments230203 
Other current assets411
Other undisclosed current assets652
Total current assets:302259151
Noncurrent Assets
Operating lease, right-of-use asset2
Property, plant and equipment411
Other undisclosed noncurrent assets000
Total noncurrent assets:621
TOTAL ASSETS:309260152
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities24147
Accounts payable1082
Accrued liabilities1464
Debt0  
Deferred revenue and credits0
Total current liabilities:24147
Noncurrent Liabilities
Long-term debt and lease obligation3  
Finance lease, liability3
Liabilities, other than long-term debt 00
Deferred revenue and credits0
Deferred rent credit 0
Total noncurrent liabilities:300
Total liabilities:28147
Stockholders' equity
Stockholders' equity attributable to parent281246145
Common stock000
Additional paid in capital606431255
Accumulated deficit(325)(185)(110)
Total stockholders' equity:281246145
TOTAL LIABILITIES AND EQUITY:309260152

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Gross profit:  (0)
Operating expenses(146)(78)(32)
Other undisclosed operating income  0
Operating loss:(146)(78)(32)
Nonoperating income (expense)54(1)
Investment income, nonoperating541
Net loss attributable to parent:(141)(74)(34)
Preferred stock dividends and other adjustments  (4)
Net loss available to common stockholders, diluted:(141)(74)(38)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
Net loss:(141)(74)(34)
Other comprehensive loss(141)  
Comprehensive loss, net of tax, attributable to parent:(281)(74)(34)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: